These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 34528543

  • 1. Prognostic impact of the 18F-fluorodeoxyglucose positron-emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer.
    Goksel S, Cengiz A, Ozturk H, Yurekli Y.
    J Cancer Res Ther; 2021; 17(4):925-930. PubMed ID: 34528543
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
    Mirili C, Guney IB, Paydas S, Seydaoglu G, Kapukaya TK, Ogul A, Gokcay S, Buyuksimsek M, Yetisir AE, Karaalioglu B, Tohumcuoglu M.
    Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 4. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A, Mohan A, Bhalla AS, Sharma MC, Vishnubhatla S, Das CJ, Pandey AK, Sekhar Bal C, Patel CD, Sharma P, Agarwal KK, Kumar R.
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y.
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [Abstract] [Full Text] [Related]

  • 6. Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.
    Lim CH, Hyun SH, Moon SH, Cho YS, Choi JY, Lee KH.
    Eur Radiol; 2019 Oct; 29(10):5288-5297. PubMed ID: 30899978
    [Abstract] [Full Text] [Related]

  • 7. Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.
    Sun M, Lu D, Li X, Wang J, Zhang L, Yang P, Yang Y, Shen J.
    Cancer Med; 2024 Sep; 13(18):e70216. PubMed ID: 39302034
    [Abstract] [Full Text] [Related]

  • 8. Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
    Castello A, Toschi L, Rossi S, Finocchiaro G, Grizzi F, Mazziotti E, Qehajaj D, Rahal D, Lopci E.
    Clin Lung Cancer; 2020 Jan; 21(1):28-36. PubMed ID: 31409523
    [Abstract] [Full Text] [Related]

  • 9. Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.
    Wang D, Koh ES, Descallar J, Pramana A, Vinod SK, Ho Shon I.
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):349-358. PubMed ID: 27550522
    [Abstract] [Full Text] [Related]

  • 10. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
    Koh YW, Lee SJ, Park SY.
    Lung Cancer; 2017 Feb; 104():31-37. PubMed ID: 28212997
    [Abstract] [Full Text] [Related]

  • 11. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD, Wang HC, Wang YB, Cui LL, Chen XH.
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer.
    Kumasaka S, Nakajima T, Arisaka Y, Tokue A, Achmad A, Fukushima Y, Shimizu K, Kaira K, Higuchi T, Tsushima Y.
    BMC Med Imaging; 2018 Nov 26; 18(1):46. PubMed ID: 30477476
    [Abstract] [Full Text] [Related]

  • 13. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.
    Yanarateş A, Yazici B.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Nov 26; 39(1):3-8. PubMed ID: 31818695
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A, Yersal Ö, Ömürlü İK, Yürekli Y.
    Indian J Cancer; 2023 Nov 26; 60(2):224-229. PubMed ID: 37530245
    [Abstract] [Full Text] [Related]

  • 15. Metabolic tumor volume derived from 18F-FDG PET/CT as a prognostic parameter for non-small cell lung cancer (NSCLC) patients.
    Ding C, Mao X, Li N, Huang M, Huang Z, Bao W, Li H, Fan J.
    Hell J Nucl Med; 2022 Nov 26; 25(1):63-70. PubMed ID: 35503557
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 26; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 17. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb 26; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 18. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW, Lee KY, Kim HJ, Kim WS, So Y.
    J Cancer Res Clin Oncol; 2014 Jan 26; 140(1):89-98. PubMed ID: 24194352
    [Abstract] [Full Text] [Related]

  • 19. Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
    Bojaxhiu B, Sinovcic D, Elicin O, Templeton AJ, Shelan M, Wartenberg J, Alberts I, Rominger A, Aebersold DM, Zaugg K.
    Radiat Oncol; 2022 Aug 13; 17(1):141. PubMed ID: 35964056
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
    Aktas GE, Karamustafaoğlu YA, Balta C, Süt N, Sarikaya İ, Sarikaya A.
    Nucl Med Commun; 2018 Nov 13; 39(11):995-1004. PubMed ID: 30188416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.